The golden aluminum brand, which is under the biological banner of the siangian aluminum, and focuses on the regulation of gout, is supported by the guangxi province institute for the study of aluminum pilgrimosis. The product has been tested for over three years and over 10,000 cases. It has been determined that the acetaminomas, bioalkalis and acetone, among others, have significantly reduced and dissolved the high ureaemia and urea acid crystals in the agonite population, a landmark discovery that has raised hopes for the ailated populations. In 2013, the development of a pain rehabilitation product was proposed. In 2014, the west angne bioscientific group was established to establish the "golden cube" brand and to begin the pre-heat layout of the brand market. In 2018, a successful development of the golden acetylene fluent acid powder was completed, with the product entering the design packaging, planning for entry, and direct shop specialty. Since 2019, 300 additional union stores have been added each year, bringing the total number of union stores to 1,000 by 2021. In 2021, the project joined the siena institute of health businesses to develop a sound project business theory and an entrepreneurial training package. In 2024, the listing scheme was launched and placed on the new board. No matter how bright the future may be, the golden aluminum brand will be based on reality, now on a credible brand that will bring hope and love to the arrhythmia and help the arrhythmia to regain confidence。